1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with angiotensin ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graham, D; Guzik, TJ; Justo-Junior, AS; Kiss, AK; Kowalczyk, P; Koziol, J; Kusmierczyk, Z; Luc, K; Maffia, P; Mazur, M; Mikolajczyk, TP; Naruszewicz, M; Nosalski, R; Schramm-Luc, A; Skiba, DS | 1 |
| Dhital, S; Eberth, JF; Hasanain, S; Lane, BA; Lessner, SM; Nosoudi, N; Parasaram, V; Vyavahare, NR; Wang, X | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and angiotensin ii
| Article | Year |
|---|---|
1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Humans; Hydrolyzable Tannins; Hypertension; Inflammation; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Oenothera; Tumor Cells, Cultured; Ventricular Dysfunction | 2019 |
Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice.
Topics: Angiotensin II; Animals; Antibodies; Aortic Aneurysm, Abdominal; Drug Delivery Systems; Elastin; Hydrolyzable Tannins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Serum Albumin, Bovine | 2021 |